Massachusetts Eye and Ear and Massachusetts General Hospital advancied gene-based COVID-19 vaccine
On May 5, 2020, Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham,…
-
-
SHERLOCK-based one-step test provided rapid and sensitive COVID-19 detection
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
-
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
-
Pfizer and BioNTech dosed first participants in US as part of global COVID-19 mRNA vaccine development program
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
-
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDS
On May 5, 2020, Athersys announced that the first patients have been enrolled in Athersys’ pivotal Phase 2/3…
-
Athersys announced commencement of patient enrollment in MACOVIA Study, a pivotal phase 2/3 trial evaluating MultiStem cell therapy for COVID-19 induced ARDS
On May 5, 2020, Athersys announced the first patients have been enrolled in Athersys’ pivotal Phase 2/3 study…
-
Miami University confirmed high quality of IGEA’s COVID-19 rapid test
On May 5, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
-
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics Corp. (MVC) announced a global commercial license agreement with National Institutes…
-
ACON Laboratories announced international availability of SARS-CoV-2 rapid test
On May 5, 2020, ACON Laboratories announced the availability of its SARS-COV-2 IgG/IgM Rapid Test. ACON’s test is…
-
TGen and HonorHealth initiated COVID-19 combination therapy of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection
On May 5, 2020, the HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination…
-
Agriculture | Biotechnology | COVID-19 | Diagnostics | Infectious Disease | USDA | Vaccine
Tyson Foods Fresh Meats resumed Waterloo, Iowa operations
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
-
Biotechnology | COVID-19 | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics
USPTO launched platform to facilitate connections between patent holders and potential licensees in key technologies
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
-
BIOFIRE respiratory panel 21 (RP21) with SARS-CoV-2 obtained FDA Emergency Use Authorization
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
-
Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
-
Eli Lilly and Junshi Biosciences to co-develop antibody therapies for pevention and treatment of COVID-19
On May 4, 2020, Junshi Biosciences and Eli Lilly announced they have entered into an agreement to co-develop therapeutic…
-
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
-
Arcturus Therapeutics and Catalent announced partnership to manufacture mRNA-Based COVID-19 vaccine
On May 4, 2020, Arcturus Therapeutics and Catalent announced a partnership to support the expected manufacture of Arcturus’…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Pharmaceutical | Therapeutics
Government of Canada Investing in global race to find a treatment for COVID-19
On May 3, 2020, the Government of Canada announced it was investing in projects that support the global…
-
Timing of immune response to COVID-19 may contribute to disease severity
On May 1, 2020, a new University of Southern California (USC) study suggests that temporarily suppressing the body’s immune…
-
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
-
CDC launched national viral genomics consortium to better map SARS-CoV-2 transmission
On May 1, 2020, the U.S. Centers for Disease Control and Prevention (CDC) launched the SARS-CoV-2 Sequencing for…
-
CHF Solutions shipped Aquadex product to COVID-19 specialty center in Minnesota
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
-
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
-
XBiotech identified ‘super bloods’ for development of True Human COVID-19 therapy
On May 1, 2020, XBiotech announced that human immune donors have now been identified that can support the Company’s…
-
Gilead announced investigational antiviral remdesivir received FDA Emergency Use Authorization for treatment of COVID-19
On May 1, 2020, Gilead announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
FDA issued Emergency Use Authorization for potential COVID-19 treatment
On May 1, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…
-
Mesoblast began enrollment in phase 2/3 clinical trial of remestemcel-L in 300 patients with acute respiratory distress syndrome
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
-
AstraZeneca and Oxford University announced landmark agreement for COVID-19 vaccine
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
-
Oxford University announced a landmark partnership for development of COVID-19 vaccine
On Apr. 30, 2020, University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for…
-
Fujifilm Diosynth teamed with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity for COVID-19 therapies
On Apr. 30, 2020, FUJIFILM announced that it will reserve manufacturing capacity for a future COVID-19 therapy for…
